Division of Cardiovascular Medicine, Department of Medicine, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43614, USA.
Am J Cardiovasc Drugs. 2013 Oct;13(5):325-30. doi: 10.1007/s40256-013-0027-2.
Benzocaine is a widely used topical oropharyngeal anesthetic and has been reported to cause methemoglobinemia. We discuss benzocaine-induced methemoglobinemia and review the causes, presentation, and management of this serious complication. Treatment with methylene blue will result in reversal of methemoglobinemia and clinical recovery in most cases but needs to be used at appropriate doses in carefully selected individuals. Physicians who perform procedures involving the application of benzocaine for topical anesthesia need to rapidly identify and treat methemoglobinemia to avoid significant associated morbidity and mortality.
苯佐卡因是一种广泛应用于局部口腔的麻醉剂,据报道可引起高铁血红蛋白血症。我们讨论了苯佐卡因引起的高铁血红蛋白血症,并回顾了这种严重并发症的病因、表现和处理方法。亚甲蓝治疗可使高铁血红蛋白血症逆转并使大多数患者的临床情况恢复,但需要在仔细选择的个体中使用适当剂量。行涉及苯佐卡因局部麻醉应用的操作的医生需要快速识别和治疗高铁血红蛋白血症,以避免严重的相关发病率和死亡率。